Hypnotic activity and effects on performance of lormetazepam and camazepam--analogues of temazepam
- PMID: 6120717
- PMCID: PMC1402107
- DOI: 10.1111/j.1365-2125.1982.tb01398.x
Hypnotic activity and effects on performance of lormetazepam and camazepam--analogues of temazepam
Abstract
1 The effects of lormetazepam and camazepam on sleep electroencephalography, visuo-motor coordination, digit symbol substitution and subjective assessments of mood and sleep quality were compared with placebo in six young adult males (18-27 years). The study was double blind. 2 Over the dose range 0.5, 1.0 and 2.0 mg, lormetazepam increased total sleep time (P less than 0.05), reduced wakefulness (P less than 0.05) and drowsy sleep (linear effect P less than 0.05). With 2.0 mg there were increases in stage 3 (P less than 0.05) and reduction in rapid eye movement sleep (P less than 0.01). Overnight ingestion of 2.0 mg, was followed by impaired visuo-motor coordination and fewer substitutions with the digit symbol test. 3 The hypnotic effect of 10-20 mg camazepam was limited to reduced awake activity (P less than 0.05), and with 20 mg there were increased substitutions on the digit symbol test. After 40 mg overnight stage 4 sleep was reduced (P less than 0.001) and performance at the digit symbol test was impaired (P less than 0.05 at 9.75 h). Morning ingestion of 20 mg camazepam did not alter performance, and the subjects assessed themselves to be more relaxed. 4 Lormetazepam is not specially indicated for those involved in skilled activity, but may prove useful for patients with insomnia resistant to other drugs. Camazepam would appear to be a promising anxiolytic with minimal effects on performance.
Similar articles
-
Hypnotic activity of lormetazepam and camazepam.Br J Clin Pharmacol. 1983 May;15(5):573-5. doi: 10.1111/j.1365-2125.1983.tb02095.x. Br J Clin Pharmacol. 1983. PMID: 6134544 Free PMC article. No abstract available.
-
Amnesic effects of lormetazepam.Psychopharmacology Suppl. 1984;1:165-72. doi: 10.1007/978-3-642-69659-6_14. Psychopharmacology Suppl. 1984. PMID: 6147838 Clinical Trial.
-
Comparison between the central effects of camazepam and temazepam. Computerized analysis of sleep recordings.Neuropsychobiology. 1984;11(1):72-6. doi: 10.1159/000118055. Neuropsychobiology. 1984. PMID: 6146112 Clinical Trial.
-
Temazepam: a review of its pharmacological properties and therapeutic efficacy as an hypnotic.Drugs. 1981 May;21(5):321-40. doi: 10.2165/00003495-198121050-00001. Drugs. 1981. PMID: 6112127 Review.
-
Lormetazepam, memory and information processing: a review.Psychopharmacol Ser. 1988;6:169-79. doi: 10.1007/978-3-642-73288-1_12. Psychopharmacol Ser. 1988. PMID: 2905805 Review.
Cited by
-
Hypnotic activity of lormetazepam and camazepam.Br J Clin Pharmacol. 1983 May;15(5):573-5. doi: 10.1111/j.1365-2125.1983.tb02095.x. Br J Clin Pharmacol. 1983. PMID: 6134544 Free PMC article. No abstract available.
-
Residual effects of lormetazepam on mood and performance in healthy elderly volunteers.Eur J Clin Pharmacol. 1991;40(3):267-71. doi: 10.1007/BF00315207. Eur J Clin Pharmacol. 1991. PMID: 2060563 Clinical Trial.
-
Effects of a mu-opioid receptor agonist (codeine phosphate) on visuo-motor coordination and dynamic visual acuity in man.Br J Clin Pharmacol. 1986 Nov;22(5):507-12. doi: 10.1111/j.1365-2125.1986.tb02928.x. Br J Clin Pharmacol. 1986. PMID: 3024689 Free PMC article. Clinical Trial.
-
Dose level effects of triazolam on sleep and response to a smoke detector alarm.Psychopharmacology (Berl). 1987;91(4):397-402. doi: 10.1007/BF00216003. Psychopharmacology (Berl). 1987. PMID: 3108921 Clinical Trial.
-
The role of benzodiazepines in common conditions: a narrative review focusing on lormetazepam.Int Clin Psychopharmacol. 2024 May 1;39(3):139-147. doi: 10.1097/YIC.0000000000000529. Epub 2024 Feb 13. Int Clin Psychopharmacol. 2024. PMID: 38277240 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources